ODA Spending

How much ODA does the US allocate to global health?

In 2023, the US was the largest donor to global health, providing US$9.6billion in health ODA. The US spent 15% of its development assistance on global health.

How does the US allocate global health ODA?

As with its overall development budget, the US channeled the majority of its ODA bilaterally in 2023.

Bilateral Spending

The US spent 84% of its ODA to health as bilateral ODA in 2023, including earmarked funding through multilaterals.

Multilateral Spending and Commitments

The remaining 15% of the US’ health ODA was channeled as core funding to multilaterals. In March 2025, it was announced that the Trump administration plans to withdraw funding for Gavi and end key programs supporting malaria prevention. The loss of US funds will set back Gavi's ability to continue providing basic services, like immunizations for measles and polio. By Gavi’s estimate, the loss of US support may mean 75 million children do not receive routine vaccinations in the next five years, resulting in over 1.2 million child deaths.

Funding and Policy Outlook

What is the current government's outlook on global health ODA?

Global health has traditionally received bipartisan support, including for PEPFAR, which is the largest bilateral global health programs: Despite this, global health was cut slightly from FY2023 to FY2024, down from US$10.6 billion to US$10 billion. Global health security saw increases in the wake of COVID-19. In the 2025 restructuring of USAID, some programs combating tuberculosis and HIV were preserved in the face of widespread cuts.

Global health emerged as a focus of the US’ ODA following the COVID-19 pandemic: In 2021, Biden allocated US$3.5 billion to the Global Fund and US$5.2 billion to USAID. Biden also launched a National Security Council Directorate on Global Health Security and Biodefense. In July 2021, the Biden administration released a US COVID-19 Global Response and Recovery Framework to end the pandemic, mitigate its negative impacts, and strengthen future pandemic preparedness.

Key Bodies

Global health R&D is also important to addressing many of the global health challenges that disproportionately affect the world’s most disadvantaged people. For more information on how donor countries are supporting global health R&D across three main areas — 1) EIDs; 2) PRNDs; and 3) SRH — read the excellent G-Finder reports and explore the interactive data portal created by Policy Cures Research. Not all funding mentioned in these analyses qualifies as ODA.